Literature DB >> 16640824

Eastern Cooperative Oncology Group 4402: Rituximab Extended Schedule or Retreatment Trial (RESORT).

Brad S Kahl1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16640824     DOI： 10.3816/CLM.2006.n.024

Source DB:  PubMed          Journal:  Clin Lymphoma Myeloma        ISSN： 1557-9190


× No keyword cloud information.
  2 in total

Review 1.  Rituximab maintenance versus radioimmunotherapy consolidation in follicular lymphoma: which, when, and for whom?

Authors:  Roswitha Forstpointner; Martin Dreyling
Journal:  Curr Hematol Malig Rep       Date:  2011-12       Impact factor: 3.952

2.  Regulation of CD20 in rituximab-resistant cell lines and B-cell non-Hodgkin lymphoma.

Authors:  Ping-Chiao Tsai; Francisco J Hernandez-Ilizaliturri; Naveen Bangia; Scott H Olejniczak; Myron S Czuczman
Journal:  Clin Cancer Res       Date:  2012-01-06       Impact factor: 12.531
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.